关注
Nicole Croteau
Nicole Croteau
Research Analyst at University of British Columbia
在 ubc.ca 的电子邮件经过验证
标题
引用次数
引用次数
年份
Efficacy of nivolumab and pembrolizumab in patients with advanced non–small-cell lung cancer needing treatment interruption because of adverse events: a retrospective …
D Ksienski, ES Wai, N Croteau, L Fiorino, E Brooks, Z Poonja, D Fenton, ...
Clinical lung cancer 20 (1), e97-e106, 2019
842019
Sex differences in presentation and outcome after an acute transient or minor neurologic event
YX Amy, AM Penn, ML Lesperance, NS Croteau, RF Balshaw, K Votova, ...
JAMA neurology 76 (8), 962-968, 2019
612019
Pembrolizumab for advanced nonsmall cell lung cancer: Efficacy and safety in everyday clinical practice
D Ksienski, ES Wai, N Croteau, AT Freeman, A Chan, L Fiorino, ...
Lung Cancer 133, 110-116, 2019
502019
Prognostic significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for advanced non-small cell lung cancer patients with high PD-L1 tumor expression …
D Ksienski, ES Wai, D Alex, NS Croteau, AT Freeman, A Chan, ...
Translational lung cancer research 10 (1), 355, 2021
342021
Association of age with differences in immune related adverse events and survival of patients with advanced nonsmall cell lung cancer receiving pembrolizumab or nivolumab
D Ksienski, ES Wai, NS Croteau, AT Freeman, A Chan, L Fiorino, ...
Journal of Geriatric Oncology 11 (5), 807-813, 2020
252020
Differential proteomics for distinguishing ischemic stroke from controls: a pilot study of the SpecTRA project
AM Penn, V Saly, A Trivedi, ML Lesperance, K Votova, AM Jackson, ...
Translational stroke research 9, 590-599, 2018
172018
Validation of a proteomic biomarker panel to diagnose minor-stroke and transient ischaemic attack: phase 2 of SpecTRA, a large scale translational study
AM Penn, MB Bibok, VK Saly, SB Coutts, ML Lesperance, RF Balshaw, ...
Biomarkers 23 (8), 793-803, 2018
172018
Verification of a proteomic biomarker panel to diagnose minor stroke and transient ischaemic attack: phase 1 of SpecTRA, a large scale translational study
AM Penn, MB Bibok, VK Saly, SB Coutts, ML Lesperance, RF Balshaw, ...
Biomarkers 23 (4), 392-405, 2018
172018
White matter hyperintensity volume influences symptoms in patients presenting with minor neurological deficits
C Zerna, AYX Yu, ZM Hong, AM Penn, ML Lesperance, NS Croteau, ...
Stroke 51 (2), 409-415, 2020
102020
Acquisition of L2 Japanese WH questions: Evidence of phonological contiguity and non-shallow structures
J Archibald, N Croteau
Second Language Research 37 (4), 649-679, 2021
82021
Individualized prescribing portraits to reduce inappropriate initiation of opioid analgesics to opioid naïve patients in primary care: Protocol for a randomized controlled trial
J Klimas, MA Hamilton, G Carney, IR Cooper, NS Croteau, H Dong, ...
Contemporary Clinical Trials 107, 106462, 2021
82021
Treatment of non-small-cell lung cancer after progression on nivolumab or pembrolizumab
AT Freeman, M Lesperance, ES Wai, NS Croteau, L Fiorino, G Geller, ...
Current Oncology 27 (2), 76-82, 2020
82020
Systolic blood pressure as a predictor of transient ischemic attack/minor stroke in emergency department patients under age 80: a prospective cohort study
AM Penn, NS Croteau, K Votova, C Sedgwick, RF Balshaw, SB Coutts, ...
BMC neurology 19, 1-10, 2019
82019
Immune related adverse events and treatment discontinuation in patients older and younger than 75 years with advanced melanoma receiving nivolumab or pembrolizumab
D Ksienski, PT Truong, NS Croteau, A Chan, E Sonke, T Patterson, ...
Journal of Geriatric Oncology 13 (2), 220-227, 2022
72022
Survival outcomes following discontinuation of ipilimumab and nivolumab for advanced melanoma in a population-based cohort
D Ksienski, PT Truong, ES Wai, NS Croteau, A Chan, T Patterson, ...
Clinical Oncology 33 (12), e561-e569, 2021
62021
Characteristics and incidence of opioid analgesic initiations to opioid naïve patients in a Canadian primary care setting
J Klimas, MA Hamilton, G Carney, IR Cooper, NS Croteau, H Dong, ...
Canadian Journal of Addiction 13 (1), 43-50, 2022
42022
27-gene Immuno-Oncology (IO) score is associated with efficacy of checkpoint immunotherapy in advanced NSCLC: a retrospective BC cancer study
DL Saltman, MG Varga, TJ Nielsen, NS Croteau, HM Lockyer, AL Jain, ...
Clinical Lung Cancer 24 (2), 137-144, 2023
32023
Reducing time-to-unit among patients referred to an outpatient stroke assessment unit with a novel triage process: a prospective cohort study
MB Bibok, K Votova, RF Balshaw, ML Lesperance, NS Croteau, A Trivedi, ...
BMC Health Services Research 18, 1-9, 2018
32018
Treatment Outcomes of Low-grade Lymphoma of the Orbit
CL Holloway, T Pickles, NS Croteau, ES Wai
Clinical Oncology 34 (7), E298-E304, 2022
22022
Time to Treatment With Nivolumab or Pembrolizumab for Patients With Advanced Melanoma in Everyday Practice
D Ksienski, PT Truong, NS Croteau, A Chan, E Sonke, T Patterson, ...
Cureus 13 (11), 2021
12021
系统目前无法执行此操作,请稍后再试。
文章 1–20